bioLytical Laboratories Once Again Named as One of BC’s Fastest-Growing Companies for the Sixth Year

Each year, BIV researches companies headquartered in BC to determine our province’s fastest-growing companies by revenue growth over the previous five years. The annual listing highlights BC companies in different industries, including Life Sciences and Biotech. We are pleased to represent British Columbia on the national and global stages and are excited to continue providing innovative diagnostic solutions for some of the world’s most pressing health concerns. We have been named to the list each year since 2017, making this year our sixth consecutive year, showcasing the impressive work and dedication of our bioLytical team.

Since last year’s list, we launched our new platform, iStatis, to continue creating reliable access to testing. With additional lateral flow technology in its portfolio, we continue to innovate and find new solutions for infectious disease diagnostics. In 2022, we received Health Canada authorization and our CE Mark for our iStatis COVID-19 Antigen Test for both professional and home use, furthering our ability to play an integral role in addressing the most severe public health challenges.

As the world continues to evolve towards innovative and personalized healthcare solutions, bioLytical is at the forefront, creating effective solutions for rapid testing with our unique flow-through INSTI® technology and our iStatis lateral flow platform. With the world’s fastest HIV, HCV, syphilis, and COVID-19 antibody tests and our new COVID-19 antigen tests, bioLytical offers a comprehensive platform to help end epidemics by providing accurate and convenient tests.